Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study - PubMed

Long term use of systemic hormone therapy might be accompanied with an overall increased risk of Alzheimer's disease, which is not related to the type of progestogen or the age at initiation of systemic hormone therapy. By contrast, use of vaginal estradiol shows no such risk. Even though the absolu…